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A-kinase anchor protein 75 increases the rate and magnitude of
cAMP signaling to the nucleus
Antonio Feliciello*†, Ying Li*, Enrico V. Avvedimento‡, Max E. Gottesman†
and Charles S. Rubin*
A-kinase anchor protein 75 (AKAP75) binds regulatory
subunits (RIIa and RIIb) of type II protein kinase A
(PKAII) isoforms and targets the resulting complexes to
sites in the cytoskeleton that abut the plasma
membrane [1–7]. Co-localization of AKAP75–PKAII with
adenylate cyclase and PKA substrate/effector proteins
in cytoskeleton and plasma membrane effects a
physical and functional integration of up-stream and
downstream signaling proteins, thereby ensuring
efficient propagation of signals carried by locally
generated cyclic AMP (cAMP) [4–9]. An important, but
previously untested, prediction of the AKAP model is
that efficient, cyclic nucleotide-dependent liberation of
diffusible PKA catalytic subunits from cytoskeleton-
bound AKAP75–PKAII complexes will also enhance
signaling to distal organelles, such as the nucleus. We
tested this idea by using HEK-A75 cells, in which PKAII
isoforms are immobilized in cortical cytoskeleton by
AKAP75. Abilities of HEK-A75 and control cells (with
cytoplasmically dispersed PKAII isoforms) to respond
to increases in cAMP content were compared. Cells
with anchored PKAII exhibited a threefold higher level
of nuclear catalytic subunit content and 4–10-fold
greater increments in phosphorylation of a regulatory
serine residue in cAMP response element binding
protein (CREB) and in phosphoCREB-stimulated
transcription of the c-fos gene. Each effect occurred
more rapidly in cells containing targeted AKAP75–PKAII
complexes. Thus, anchoring of PKAII in actin cortical
cytoskeleton increases the rate, magnitude and
sensitivity of cAMP signaling to the nucleus. 
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Results and discussion
The coupling of adenylate cyclase activation at the cell
surface to mRNA induction involves dissociation of PKA
holoenzyme, translocation of the catalytic (C) subunits to
the nucleus, phosphorylation of the transcription factor
CREB at Ser 133 and phosphoCREB/co-activator mediated
activation of gene transcription (reviewed in [10]). To
study effects of AKAP75 on nuclear cAMP signaling, the
AKAP-deficient human HEK293 cell line [11] was used as
a recipient for transgenes encoding anchor proteins. Stably
transfected cells that express AKAP75 or AKAP45 were
created [6,7,11]. AKAP45, which is derived from AKAP75
by deletion of residues 1–180, binds PKAII isoforms, but
lacks domains that mediate anchoring [6,11,12]. AKAP75
targeted and anchored >90% of RIIα and RIIβ in the corti-
cal actin cytoskeleton that lies adjacent to the plasma
membrane [6,7]. In contrast, RII isoforms were dispersed
in the cytoplasm of control cells and in cells expressing
AKAP45 [6,7,11]. 
Transcription of c-fos is activated through an upstream
cAMP-responsive element (CRE) [10]. Thus, effects of
anchored PKA on transcription were assessed by monitoring
synthesis of c-fos mRNA. Cells were incubated in medium
containing 0.1% fetal calf serum for 12 hours and were then
treated with forskolin (FSK) to stimulate adenylate cyclase
and 3-isobutyl-1-methylxanthine (IBMX) to inhibit cAMP
phosphodiesterases. In control cells, a low level of c-fos
mRNA was detected 30 minutes after activation of adeny-
late cyclase. The c-fos mRNA content increased over the
next 60 minutes and reached a peak value 90 minutes after
addition of FSK (Figure 1a,b). Induction of c-fos mRNA by
cAMP in HEK-A75 cells was more rapid and robust. A sub-
stantial amount of c-fos mRNA was detected 30 minutes
after exposure to FSK (Figure 1a). Content of c-fos mRNA
peaked at 45 minutes and then declined slowly during the
succeeding 45 minutes (Figure 1a,b). Levels of c-fos mRNA
were 4–10-fold higher in HEK-A75 cells than in control
cells during the initial phase (0–45 minutes) of adenylate
cyclase activation (Figure 1b). By 90 minutes, c-fos tran-
scripts were equally abundant in these cell lines. The kinet-
ics of c-fos mRNA accumulation in HEK-A45 cells was
indistinguishable from that observed in control cells. Subse-
quent experiments were focused on the physiologically rel-
evant, early phase of cAMP-mediated signal transduction. 
HEK-A75 cells generated 4–10-fold more c-fos mRNA
than did control cells over a range of activator concentra-
tions (Figure 1c). To exclude the possibility that AKAP75
increased the sensitivity of adenylate cyclase to FSK, we
monitored c-fos mRNA accumulation after incubating
cells with 8-chlorophenylthio-cAMP (CPT-cAMP), a
stable cAMP analog. CPT-cAMP selectively elicited a
large increase in c-fos mRNA content in cells containing
anchored PKAII (Figure 1d). A similar induction of c-fos
transcripts by CPT-cAMP was observed in HEK-A75
cells incubated with 10% fetal calf serum (Figure 1e).
Thus, serum hormones had little effect on the pattern of
cAMP-mediated c-fos mRNA accumulation in the three
cell lines.
Phosphotransferase activity of the C subunits increased
threefold in nuclei of FSK-treated HEK-A75 cells
(Figure 2a,b). Catalytic activity of C subunits in the
nucleus increased only slightly in similarly treated
control and HEK-A45 cells. The physiological significance
of enhanced nuclear translocation of C subunits was
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Northern blot analyses of c-fos mRNA content in HEK293, HEK-A75
and HEK-A45 cells. (a) Accumulation of c-fos mRNA in cells
incubated with 40 µM FSK and 0.1 mM IBMX. Representative
autoradiograms are shown. (b) The c-fos mRNA content was quantified
by scanning densitometry [6] at the indicated time points. Cells were
incubated with 40 µM FSK. Levels of c-fos mRNA are presented as
arbitrary densitometric units (ADU) and represent the mean of three
independent experiments that yielded similar results. (c) Accumulation
of c-fos mRNA in control and HEK-A75 cells exposed to the indicated
FSK concentrations for 30 min. Representative autoradiograms are
shown. Mean densitometric values (in ascending order of FSK
concentration) for c-fos mRNA content (above the basal level) were
determined from three independent experiments (expressed as ADU).
HEK293: 3, 5, 4; HEK-A75 13, 65, 55. (d) Cells were treated for
30 min with the cAMP analog CPT-cAMP, at the indicated
concentrations. Representative autoradiograms are shown. Mean
values for c-fos mRNA (above the basal value) from two independent
experiments (expressed as ADU) were HEK293: 0, 4, 6; HEK-A75: 23,
44, 35. Data are presented in ascending order of CPT-cAMP
concentration. (e) Cells grown in 10% fetal calf serum were incubated
with the indicated amounts of CPT-cAMP for 30 min. Autoradiograms
are shown. Mean values for CPT-cAMP stimulated c-fos mRNA
accumulation (from three independent experiments, expressed as
ADU) were HEK293: 8, 17; HEK-A75: 39, 45; HEK-A45: 4, 5.
evaluated by assaying CREB phosphorylation at Ser 133
by western immunoblot analysis (Figure 3). The level of
phosphorylated CREB increased modestly in control
HEK293 cells exposed to FSK. Peak phosphorylation
was evident 20 minutes after addition of drug
(Figure 3a). The kinetics and extent of phosphorylation
of CREB in HEK-A45 cells were similar. In HEK-A75
cells, a substantial increase in CREB phosphorylation
was observed 10 minutes after adenylate cyclase activa-
tion. The concentration of phosphoCREB rose sharply
for the succeeding 30 minutes. At each time point, the
amount of phosphoCREB was 5–10- fold higher in HEK-
A75 cells than in control cells. CREB phosphorylation
was also markedly increased in HEK-A75 cells at low
FSK concentrations, thereby documenting an enhanced
sensitivity to cAMP in cells with anchored PKAII
(Figure 3b). Total CREB protein in nuclear extracts did
not vary significantly during these experiments
(Figure 3a,b). Several stable, independently isolated
lines of HEK293 and hamster AV-12 cells [7] that over-
express AKAP75, exhibit properties that are similar to
those reported for HEK-A75 cells.
HEK-A75, HEK-A45 and control cells contain similar
levels of PKAII isoforms [6,7]. Synthesis and accumula-
tion of AKAP75 (in HEK-A75 cells) elicits redistribution
of holoenzyme from a large volume (cytoplasm) to a more
limited ‘compartment’ occupied by portions of cortical
actin cytoskeleton and plasma membrane [6,7]. In accord
with the AKAP model [1,2] and laws of mass action, gen-
eration of a high concentration of PKAII in the vicinity of
adenylate cyclase presumably optimizes binding of locally
produced cAMP to PKAII holoenzyme, thereby facilitat-
ing dissociation of active C subunits. Initially, PKA-medi-
ated signaling will be focused on co-localized substrates,
but subsequent C subunit diffusion is also expected.
Increases in nuclear translocation of C subunits, CREB
phosphorylation and c-fos mRNA synthesis in FSK-
treated HEK-A75 cells suggest that anchored PKAII
serves as an easily activated pool of diffusible C subunits
that mediate cAMP signaling to the nucleus. Enrichment
of PKAII in cortical cytoskeleton can substantially
increase target cell responses to modest levels of hor-
mones (that is, partial activation of adenylate cyclase),
just as increased receptor number classically increases
target cell sensitivity to low ligand concentrations. More-
over, immobilized PKAII is exposed to a maximal level of
cAMP before the cyclic nucleotide is diluted and
degraded (via cAMP phosphodiesterases) in cytoplasm.
HEK-A45 cells, which contain unanchored AKAP–PKAII
complexes, do not exhibit enhanced signaling to the
nucleus. Thus, targeting and immobilization of PKAII is
the key determinant of signal amplification; formation of
an AKAP–PKAII complex per se is necessary, but not suf-
ficient, for upregulation of cAMP-controlled gene tran-
scription. In vivo fluxes in hormone concentration often
occur on a timescale of seconds to several minutes. In this
context, the ability of cells containing anchored PKAII to
respond rapidly and with increased potency and sensitiv-
ity to modest increases in cAMP (that is, low physiologi-
cal levels of hormones) confers a considerable biological
advantage. 
Other recent observations have linked intracellular tar-
geting of PKAII to gene regulation. Overexpression of
AKAP45 in thyroid cells causes displacement of immo-
bilized PKAII from perinuclear sites (Golgi) to cytoplasm
and depresses cAMP-controlled thyroglobulin gene
expression [13]. Overexpression of AKAP75 and RII in
variant PC12 cells that are defective in cAMP signal
transduction restored cAMP-stimulated activation of a
chimeric reporter gene [14]. In these studies, however,
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Figure 2
Stimulation of nuclear translocation of C
subunits by FSK. C subunit phospho-
transferase activity was assayed in nuclear
extracts isolated from cells incubated in the
presence or absence of FSK. C activity is
expressed as the fold increase over basal
activity in response to (a) time of exposure to
40 µM FSK and 0.1 mM IBMX, or (b) various
FSK concentrations (cells harvested 20 min
after addition of drug). Values represent
phosphotransferase activity inhibitable by
50 µM PKI, which selectively binds and
inactivates C subunits. Nuclear C-specific
activity is expressed as the mean ± s.e. from
three independent experiments. C activity in
untreated cells was: 0.8 ± 0.12, 0.2 ± 0.03
and 0.8 ± 0.14 pmol per µg protein per min
for HEK293, HEK-A75 and HEK-A45 cells,
respectively.
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the exact location and composition of PKAII–anchor
protein complexes were not determined; phosphoryla-
tion and activation of CREB was not addressed and data
documenting positive regulation of an endogenous,
cAMP- and PKA-regulated target gene (for example c-
fos) was lacking. Our present results show that assembly
of AKAP75–PKAII complexes in cortical cytoskeleton
strongly promotes CREB activation via phosphorylation
at Ser 133 and a high level of expression of mRNA
encoding a key transcription factor for immediate early
genes, c-Fos. Regulation of AKAP75 content by hor-
mones or developmental factors could provide a novel
mechanism for regulating the sensitivity of cells to
agents that activate adenylate cyclase.
Materials and methods
Cell culture, transfections, assay for c-fos mRNA, protein kinase assay,
and western analysis were carried out by standard methods
[6,11–13,15,16] and are given in more detail in the Supplementary
material published with this paper on the internet.
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Figure 3
cAMP/PKA-dependent phosphorylation of CREB at Ser 133. Proteins
(30 µg) in nuclear extracts from untreated and FSK-stimulated cells
were fractionated by denaturing electrophoresis. A western blot was
probed with antiserum directed against an epitope in CREB that
includes phosphorylated Ser 133 (upper panels in (a) and (b)) or with
non-discriminating anti-CREB antibodies (lower panels). Arrows indicate
phosphorylated CREB (pCREB) and total CREB proteins. (a) Cells
were incubated with 40 µM FSK and 0.1 mM IBMX and harvested at
the indicated times. Representative immunoblots are shown. Relative
levels of the 42 kDa phosphoCREB doublet (above basal values) are
expressed as the mean of three independent experiments. The results
were HEK293: 3, 21, 19; HEK-A75: 42, 88, 150; HEK-A45: 8, 8, 10.
Values are given in ascending order of incubation times. (b) Cells were
harvested 20 min after exposure to the indicated concentrations of
FSK. Typical immunoblots are shown. Relative levels of phosphoCREB
(above basal values), expressed as the mean of three independent
experiments, were HEK293: 1, 21, 26; HEK-A75: 7, 80, 265. Values
are presented in ascending order of FSK concentration.
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